Guidance for considering ethical, legal, and social issues in health technology assessment

application to genetic screening

Beth K. Potter, Denise Avard, Ian D. Graham, Vikki A. Entwistle, Timothy A. Caulfield, Pranesh Chakraborty, Christine Kennedy, Marissa McGuire, Glenn G. Griener, Mark Montgomery, George A. Wells, Brenda J. Wilson

    Research output: Contribution to journalArticle

    17 Citations (Scopus)

    Abstract

    Objectives and Methods: Many authors have argued that ethical, legal, and social issues (“ELSIs”) should be explicitly integrated into health technology assessment (HTA), yet doing so poses challenges. This discussion may be particularly salient for technologies viewed as ethically complex, such as genetic screening. Here we provide a brief overview of contemporary discussions of the issues from the HTA literature. We then describe key existing policy evaluation frameworks in the fields of disease screening and public health genomics. Finally, we map the insights from the HTA literature to the policy evaluation frameworks, with discussion of the implications for HTA in genetic screening. Results and Conclusions: A critical discussion in the HTA literature considers the definition of ELSIs in HTA, highlighting the importance of thinking beyond ELSIs as impacts of technology. Existing HTA guidance on integrating ELSIs relates to three broad approaches: literature synthesis, involvement of experts, and consideration of stakeholder values. The thirteen key policy evaluation frameworks relating to disease screening and public health genomics identified a range of ELSIs relevant to genetic screening. Beyond straightforward impacts of screening, these ELSIs require consideration of factors such as the social and political context surrounding policy decisions. The three broad approaches to addressing ELSIs described above are apparent in the screening/genomics literatures. In integrating these findings we suggest that the method chosen for addressing ELSIs in HTA for genetic screening may determine which ELSIs are prioritized; and that an important challenge is the lack of guidance for evaluating such methods.
    Original languageEnglish
    Pages (from-to)412-422
    Number of pages11
    JournalInternational Journal of Technology Assessment in Health Care
    Volume24
    Issue number4
    DOIs
    Publication statusPublished - 2008

    Fingerprint

    Biomedical Technology Assessment
    Genetic Testing
    Genomics
    Public Health
    Technology

    Keywords

    • Genetic screening
    • Ethical, legal, and social issues
    • Health technology assessment

    Cite this

    Potter, Beth K. ; Avard, Denise ; Graham, Ian D. ; Entwistle, Vikki A. ; Caulfield, Timothy A. ; Chakraborty, Pranesh ; Kennedy, Christine ; McGuire, Marissa ; Griener, Glenn G. ; Montgomery, Mark ; Wells, George A. ; Wilson, Brenda J. / Guidance for considering ethical, legal, and social issues in health technology assessment : application to genetic screening. In: International Journal of Technology Assessment in Health Care. 2008 ; Vol. 24, No. 4. pp. 412-422.
    @article{c99ce20eecf54323862b1fe09b5624d8,
    title = "Guidance for considering ethical, legal, and social issues in health technology assessment: application to genetic screening",
    abstract = "Objectives and Methods: Many authors have argued that ethical, legal, and social issues (“ELSIs”) should be explicitly integrated into health technology assessment (HTA), yet doing so poses challenges. This discussion may be particularly salient for technologies viewed as ethically complex, such as genetic screening. Here we provide a brief overview of contemporary discussions of the issues from the HTA literature. We then describe key existing policy evaluation frameworks in the fields of disease screening and public health genomics. Finally, we map the insights from the HTA literature to the policy evaluation frameworks, with discussion of the implications for HTA in genetic screening. Results and Conclusions: A critical discussion in the HTA literature considers the definition of ELSIs in HTA, highlighting the importance of thinking beyond ELSIs as impacts of technology. Existing HTA guidance on integrating ELSIs relates to three broad approaches: literature synthesis, involvement of experts, and consideration of stakeholder values. The thirteen key policy evaluation frameworks relating to disease screening and public health genomics identified a range of ELSIs relevant to genetic screening. Beyond straightforward impacts of screening, these ELSIs require consideration of factors such as the social and political context surrounding policy decisions. The three broad approaches to addressing ELSIs described above are apparent in the screening/genomics literatures. In integrating these findings we suggest that the method chosen for addressing ELSIs in HTA for genetic screening may determine which ELSIs are prioritized; and that an important challenge is the lack of guidance for evaluating such methods.",
    keywords = "Genetic screening, Ethical, legal, and social issues, Health technology assessment",
    author = "Potter, {Beth K.} and Denise Avard and Graham, {Ian D.} and Entwistle, {Vikki A.} and Caulfield, {Timothy A.} and Pranesh Chakraborty and Christine Kennedy and Marissa McGuire and Griener, {Glenn G.} and Mark Montgomery and Wells, {George A.} and Wilson, {Brenda J.}",
    note = "dc.publisher: Cambridge University Press",
    year = "2008",
    doi = "10.1017/S0266462308080549",
    language = "English",
    volume = "24",
    pages = "412--422",
    journal = "International Journal of Technology Assessment in Health Care",
    issn = "0266-4623",
    publisher = "Cambridge University Press",
    number = "4",

    }

    Potter, BK, Avard, D, Graham, ID, Entwistle, VA, Caulfield, TA, Chakraborty, P, Kennedy, C, McGuire, M, Griener, GG, Montgomery, M, Wells, GA & Wilson, BJ 2008, 'Guidance for considering ethical, legal, and social issues in health technology assessment: application to genetic screening', International Journal of Technology Assessment in Health Care, vol. 24, no. 4, pp. 412-422. https://doi.org/10.1017/S0266462308080549

    Guidance for considering ethical, legal, and social issues in health technology assessment : application to genetic screening. / Potter, Beth K.; Avard, Denise; Graham, Ian D.; Entwistle, Vikki A.; Caulfield, Timothy A.; Chakraborty, Pranesh; Kennedy, Christine; McGuire, Marissa; Griener, Glenn G.; Montgomery, Mark; Wells, George A.; Wilson, Brenda J.

    In: International Journal of Technology Assessment in Health Care, Vol. 24, No. 4, 2008, p. 412-422.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Guidance for considering ethical, legal, and social issues in health technology assessment

    T2 - application to genetic screening

    AU - Potter, Beth K.

    AU - Avard, Denise

    AU - Graham, Ian D.

    AU - Entwistle, Vikki A.

    AU - Caulfield, Timothy A.

    AU - Chakraborty, Pranesh

    AU - Kennedy, Christine

    AU - McGuire, Marissa

    AU - Griener, Glenn G.

    AU - Montgomery, Mark

    AU - Wells, George A.

    AU - Wilson, Brenda J.

    N1 - dc.publisher: Cambridge University Press

    PY - 2008

    Y1 - 2008

    N2 - Objectives and Methods: Many authors have argued that ethical, legal, and social issues (“ELSIs”) should be explicitly integrated into health technology assessment (HTA), yet doing so poses challenges. This discussion may be particularly salient for technologies viewed as ethically complex, such as genetic screening. Here we provide a brief overview of contemporary discussions of the issues from the HTA literature. We then describe key existing policy evaluation frameworks in the fields of disease screening and public health genomics. Finally, we map the insights from the HTA literature to the policy evaluation frameworks, with discussion of the implications for HTA in genetic screening. Results and Conclusions: A critical discussion in the HTA literature considers the definition of ELSIs in HTA, highlighting the importance of thinking beyond ELSIs as impacts of technology. Existing HTA guidance on integrating ELSIs relates to three broad approaches: literature synthesis, involvement of experts, and consideration of stakeholder values. The thirteen key policy evaluation frameworks relating to disease screening and public health genomics identified a range of ELSIs relevant to genetic screening. Beyond straightforward impacts of screening, these ELSIs require consideration of factors such as the social and political context surrounding policy decisions. The three broad approaches to addressing ELSIs described above are apparent in the screening/genomics literatures. In integrating these findings we suggest that the method chosen for addressing ELSIs in HTA for genetic screening may determine which ELSIs are prioritized; and that an important challenge is the lack of guidance for evaluating such methods.

    AB - Objectives and Methods: Many authors have argued that ethical, legal, and social issues (“ELSIs”) should be explicitly integrated into health technology assessment (HTA), yet doing so poses challenges. This discussion may be particularly salient for technologies viewed as ethically complex, such as genetic screening. Here we provide a brief overview of contemporary discussions of the issues from the HTA literature. We then describe key existing policy evaluation frameworks in the fields of disease screening and public health genomics. Finally, we map the insights from the HTA literature to the policy evaluation frameworks, with discussion of the implications for HTA in genetic screening. Results and Conclusions: A critical discussion in the HTA literature considers the definition of ELSIs in HTA, highlighting the importance of thinking beyond ELSIs as impacts of technology. Existing HTA guidance on integrating ELSIs relates to three broad approaches: literature synthesis, involvement of experts, and consideration of stakeholder values. The thirteen key policy evaluation frameworks relating to disease screening and public health genomics identified a range of ELSIs relevant to genetic screening. Beyond straightforward impacts of screening, these ELSIs require consideration of factors such as the social and political context surrounding policy decisions. The three broad approaches to addressing ELSIs described above are apparent in the screening/genomics literatures. In integrating these findings we suggest that the method chosen for addressing ELSIs in HTA for genetic screening may determine which ELSIs are prioritized; and that an important challenge is the lack of guidance for evaluating such methods.

    KW - Genetic screening

    KW - Ethical, legal, and social issues

    KW - Health technology assessment

    U2 - 10.1017/S0266462308080549

    DO - 10.1017/S0266462308080549

    M3 - Article

    VL - 24

    SP - 412

    EP - 422

    JO - International Journal of Technology Assessment in Health Care

    JF - International Journal of Technology Assessment in Health Care

    SN - 0266-4623

    IS - 4

    ER -